These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
278 related items for PubMed ID: 11278665
1. MAPK/ERK overrides the apoptotic signaling from Fas, TNF, and TRAIL receptors. Tran SE, Holmstrom TH, Ahonen M, Kahari VM, Eriksson JE. J Biol Chem; 2001 May 11; 276(19):16484-90. PubMed ID: 11278665 [Abstract] [Full Text] [Related]
2. Inhibition of mitogen-activated kinase signaling sensitizes HeLa cells to Fas receptor-mediated apoptosis. Holmström TH, Tran SE, Johnson VL, Ahn NG, Chow SC, Eriksson JE. Mol Cell Biol; 1999 Sep 11; 19(9):5991-6002. PubMed ID: 10454546 [Abstract] [Full Text] [Related]
3. Mitogen-activated protein kinase/extracellular signal-regulated kinase signaling in activated T cells abrogates TRAIL-induced apoptosis upstream of the mitochondrial amplification loop and caspase-8. Söderström TS, Poukkula M, Holmström TH, Heiskanen KM, Eriksson JE. J Immunol; 2002 Sep 15; 169(6):2851-60. PubMed ID: 12218097 [Abstract] [Full Text] [Related]
4. Inhibition of death receptor-mediated gene induction by a cycloheximide-sensitive factor occurs at the level of or upstream of Fas-associated death domain protein (FADD). Wajant H, Haas E, Schwenzer R, Muhlenbeck F, Kreuz S, Schubert G, Grell M, Smith C, Scheurich P. J Biol Chem; 2000 Aug 11; 275(32):24357-66. PubMed ID: 10823821 [Abstract] [Full Text] [Related]
5. Tumor necrosis factor-related apoptosis-inducing ligand receptors signal NF-kappaB and JNK activation and apoptosis through distinct pathways. Hu WH, Johnson H, Shu HB. J Biol Chem; 1999 Oct 22; 274(43):30603-10. PubMed ID: 10521444 [Abstract] [Full Text] [Related]
6. Sensitization to death receptor cytotoxicity by inhibition of fas-associated death domain protein (FADD)/caspase signaling. Requirement of cell cycle progression. Lüschen S, Ussat S, Scherer G, Kabelitz D, Adam-Klages S. J Biol Chem; 2000 Aug 11; 275(32):24670-8. PubMed ID: 10827087 [Abstract] [Full Text] [Related]
7. Caspase inhibitors induce a switch from apoptotic to proinflammatory signaling in CD95-stimulated T lymphocytes. Scheller C, Sopper S, Ehrhardt C, Flory E, Chen P, Koutsilieri E, Ludwig S, ter Meulen V, Jassoy C. Eur J Immunol; 2002 Sep 11; 32(9):2471-80. PubMed ID: 12207331 [Abstract] [Full Text] [Related]
8. Protein kinase C modulates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by targeting the apical events of death receptor signaling. Harper N, Hughes MA, Farrow SN, Cohen GM, MacFarlane M. J Biol Chem; 2003 Nov 07; 278(45):44338-47. PubMed ID: 12920112 [Abstract] [Full Text] [Related]
9. Cytoprotection by Jun kinase during nitric oxide-induced cardiac myocyte apoptosis. Andreka P, Zang J, Dougherty C, Slepak TI, Webster KA, Bishopric NH. Circ Res; 2001 Feb 16; 88(3):305-12. PubMed ID: 11179198 [Abstract] [Full Text] [Related]
10. Inhibition of p38 kinase reveals a TNF-alpha-mediated, caspase-dependent, apoptotic death pathway in a human myelomonocyte cell line. Varghese J, Chattopadhaya S, Sarin A. J Immunol; 2001 Jun 01; 166(11):6570-7. PubMed ID: 11359809 [Abstract] [Full Text] [Related]
11. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand. Mitsiades N, Poulaki V, Tseleni-Balafouta S, Koutras DA, Stamenkovic I. Cancer Res; 2000 Aug 01; 60(15):4122-9. PubMed ID: 10945619 [Abstract] [Full Text] [Related]
12. Fas-associated death domain protein and caspase-8 are not recruited to the tumor necrosis factor receptor 1 signaling complex during tumor necrosis factor-induced apoptosis. Harper N, Hughes M, MacFarlane M, Cohen GM. J Biol Chem; 2003 Jul 11; 278(28):25534-41. PubMed ID: 12721308 [Abstract] [Full Text] [Related]
13. Fas activation of the p38 mitogen-activated protein kinase signalling pathway requires ICE/CED-3 family proteases. Juo P, Kuo CJ, Reynolds SE, Konz RF, Raingeaud J, Davis RJ, Biemann HP, Blenis J. Mol Cell Biol; 1997 Jan 11; 17(1):24-35. PubMed ID: 8972182 [Abstract] [Full Text] [Related]
14. Requirement for ERK activation in cisplatin-induced apoptosis. Wang X, Martindale JL, Holbrook NJ. J Biol Chem; 2000 Dec 15; 275(50):39435-43. PubMed ID: 10993883 [Abstract] [Full Text] [Related]
15. Modulation of tumor necrosis factor apoptosis-inducing ligand- induced NF-kappa B activation by inhibition of apical caspases. Harper N, Farrow SN, Kaptein A, Cohen GM, MacFarlane M. J Biol Chem; 2001 Sep 14; 276(37):34743-52. PubMed ID: 11461927 [Abstract] [Full Text] [Related]
16. TRAIL-induced apoptosis of thyroid cancer cells: potential for therapeutic intervention. Ahmad M, Shi Y. Oncogene; 2000 Jul 13; 19(30):3363-71. PubMed ID: 10918593 [Abstract] [Full Text] [Related]
17. Implication of TNF receptor-I-mediated extracellular signal-regulated kinases 1 and 2 (ERK1/2) activation in growth of AIDS-associated Kaposi's sarcoma cells: a possible role of a novel death domain protein MADD in TNF-alpha-induced ERK1/2 activation in Kaposi's sarcoma cells. Murakami-Mori K, Mori S, Bonavida B, Nakamura S. J Immunol; 1999 Mar 15; 162(6):3672-9. PubMed ID: 10092829 [Abstract] [Full Text] [Related]
18. JNK (c-Jun N-terminal kinase) and p38 activation in receptor-mediated and chemically-induced apoptosis of T-cells: differential requirements for caspase activation. MacFarlane M, Cohen GM, Dickens M. Biochem J; 2000 May 15; 348 Pt 1(Pt 1):93-101. PubMed ID: 10794718 [Abstract] [Full Text] [Related]
19. Signaling events triggered by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL): caspase-8 is required for TRAIL-induced apoptosis. Seol DW, Li J, Seol MH, Park SY, Talanian RV, Billiar TR. Cancer Res; 2001 Feb 01; 61(3):1138-43. PubMed ID: 11221844 [Abstract] [Full Text] [Related]
20. Association of apoptosis with the inhibition of extracellular signal-regulated protein kinase activity in the tumor necrosis factor alpha-resistant ovarian carcinoma cell line UCI 101. Yazlovitskaya EM, Pelling JC, Persons DL. Mol Carcinog; 1999 May 01; 25(1):14-20. PubMed ID: 10331740 [Abstract] [Full Text] [Related] Page: [Next] [New Search]